Skip to content

Pharmacokinetic Study of Intravenous Colistin in Pediatric Population

Pharmacokinetic Study of Intravenous Colistin in Pediatric Population

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20171119001
Enrollment
Unknown
Registered
2017-11-19
Start date
2014-12-13
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children who are suspected for multi-drug resistant (MDR) gram negative bacterial infection Pharmacokinetic parameters pharmacokinetics colistin loading dose pediatric children MDROs

Interventions

loading dose 4 mg/kg IV in 5 minutes follow by maintenance dose 5 mg/kg/day divided into q 8&#45
12 hr IV in 5 minutes start after loading dose 8&#45
12 hr ,maintenance dose 5 mg/kg/day divided into q 8&#45
12 hr IV in 5 minutes
Experimental Drug,Experimental Drug
loading dose,no loading dose

Sponsors

-
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 18 Years

Inclusion criteria

Inclusion criteria: Age 2-18 years old Documented infection by multiple-resistant micro-organisms only susceptible to colistin or empirically treated for suspected MDR- GNR infection need to receive colistin at least 72 hours written informed consent

Exclusion criteria

Exclusion criteria: creatinine clearance lower than 60 mL/min/1.73m2 body weight less than 10 kg pregnant women

Design outcomes

Primary

MeasureTime frame
pharmacokinetic parameters (Cmax, Tmax, AUC, T1/2) 0, 1, 2, 4, 8, 12 or 16, 24, 48, 72 hr blood sampling and colistin plasma drug level measurement

Secondary

MeasureTime frame
Creatinine clearance every 1-3 days during colistin cource Blood for serum creatinine,urine NGAL before and 24, 72 hours after the first dose of colistin urine for NGAL

Countries

Thailand

Contacts

Public ContactNoppadol Wacharachaisurapol

Faculty of Medicine, Chulalongkorn University

noppadol.w@chula.ac.th022564481

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026